✦ LIBER ✦

Phase II trial of mta (LY231514) in patients (PTS) with non-small cell lung cancer (NSCLC) who relapsed after previous platinum or non-platinum chemotherapy

✍ Scribed by P. Postmus; K. Mattson; von Pawel; C. Manegold; E. Smit; M. Millward; S. Clarke; A. Saarinen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MTA (LY231514): a phase II trial in pati

✍ von Pawel, J.; Manegold, C.; Mattson, K.; Postmus, P.E.; Smit, E.F.; Clarke, S.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 106 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase II trial of the multi-targeted ant

✍ Rusthoven, J.; Eisenhauer, E.; Butts, C.; Gregg, R.; Dancey, J.; Fisher, B.; Igl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Phase II trial of MTA (AlimtaTM) and cis

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

210 Phase III study with gemcitabine — V

✍ Biesma, B.; Postmus, P.E. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase II trial of double platinum with c

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB